Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 22,980 | 51,778 | 38,961 | 28,814 | 24,131 |
| Operating Income | -22,980 | -51,778 | -38,961 | -28,814 | -24,131 |
| Other Income | 1,189 | 7,262 | -3,870 | -3,039 | 9 |
| Pre-tax Income | -21,791 | -44,516 | -42,831 | -31,853 | -24,122 |
| Income Tax | N/A | 66 | -60 | -60 | N/A |
| Net Income Continuous | -21,791 | -44,582 | -42,771 | -31,793 | -24,122 |
| Net Income | $-21,791 | $-44,582 | $-42,771 | $-31,793 | $-24,122 |
| EPS Basic Total Ops | -8.35 | -36.52 | -105.11 | -135.44 | -130.63 |
| EPS Basic Continuous Ops | -8.35 | -36.52 | -105.09 | -135.31 | -130.48 |
| EPS Diluted Total Ops | -8.35 | -41.89 | -105.11 | -135.44 | -130.63 |
| EPS Diluted Continuous Ops | -8.35 | -36.01 | -105.09 | -135.31 | -130.48 |
| EPS Diluted Before Non-Recurring Items | -8.35 | -46.55 | -94.60 | -121.62 | -129.13 |
| EBITDA(a) | $-22,766 | $-51,486 | $-38,768 | $-28,665 | $-23,981 |